|PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : firstname.lastname@example.org / email@example.com
Index Copernicus ICV 2015: 85.95
NAAS RATING 2017: 5.38
Pseudomonas aeruginosa is a leading cause of nosocomial infections. Infections caused by it are often severe and life threatening and difficult to treat because the organism is inherently resistant to many drug classes (MDR) and is able to acquire resistance to all effective antimicrobial drugs. Over the years, P. aeruginosa contributes substantially to morbidity and mortality related to surgical site infection (SSI) worldwide, the third most commonly reported nosocomial infection. People infected with drug-resistant organisms like P. aeruginosa are more likely to have longer and more expensive hospital stays, and may be more likely to die as a result of the infection. The study was aimed to determine the prevalence and drug resistance pattern of P. aeruginosa in SSI. Over a 2-year period, specimens were received as postoperative wound swabs in Microbiology department and processed for isolation and identification of bacterial pathogens, according to the standard microbiological techniques. Antibiotic Sensitivity test was performed on Mueller Hinton agar by Kirby Bauer’s disc diffusion method. Out of 360 bacterial organism isolated, 68 (18.89 %) were P. aeruginosa. A total of 11 (16.18%) isolates were resistant to three or more antibiotic classes (multidrug resistance). Imipenem and piperacillin/tazobactam showed high sensitivity, with 88.24% and 89.71% respectively. Continued monitoring of susceptibility pattern of P. aeruginosa from SSI need to be carried out in individual settings so as to detect the true burden of multidrug resistance in organisms and prevent their further emergence by judicious use of drugs.